SC 13G Filing

Company

ENDRA Life Sciences Inc.

Filed

March 10, 2023

Accession Number

0001967828-23-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →